Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
Herausgeber: Newton, Herbert B
Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
Herausgeber: Newton, Herbert B
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Errata slip copyright 2018 inserted at end.
Andere Kunden interessierten sich auch für
![Tumor Immunology and Immunotherapy - Molecular Methods]( "Tumor Immunology and Immunotherapy - Molecular Methods")
Tumor Immunology and Immunotherapy - Molecular Methods128,99 €![Tumor Immunology and Immunotherapy - Cellular Methods Part A]( "Tumor Immunology and Immunotherapy - Cellular Methods Part A")
Tumor Immunology and Immunotherapy - Cellular Methods Part A111,99 €![Tumor Immunology and Immunotherapy - Integrated Methods Part B]( "Tumor Immunology and Immunotherapy - Integrated Methods Part B")
Tumor Immunology and Immunotherapy - Integrated Methods Part B110,99 €![Tumor Immunology and Immunotherapy - Cellular Methods Part B]( "Tumor Immunology and Immunotherapy - Cellular Methods Part B")
Tumor Immunology and Immunotherapy - Cellular Methods Part B111,99 €![Nanotherapeutics in Cancer Vaccination and Challenges]( "Nanotherapeutics in Cancer Vaccination and Challenges")
Nanotherapeutics in Cancer Vaccination and Challenges146,99 €![Tumor Immunology and Immunotherapy - Integrated Methods Part A]( "Tumor Immunology and Immunotherapy - Integrated Methods Part A")
Tumor Immunology and Immunotherapy - Integrated Methods Part A110,99 €![Peritoneal Carcinomatosis: Drugs and Diseases]( "Peritoneal Carcinomatosis: Drugs and Diseases")
SugarbakerPeritoneal Carcinomatosis: Drugs and Diseases154,99 €-
-
-
Produktdetails
- Produktdetails
- Verlag: Elsevier Science Publishing Co Inc
- 2 ed
- Seitenzahl: 848
- Erscheinungstermin: 17. April 2018
- Englisch
- Abmessung: 276mm x 216mm x 46mm
- Gewicht: 276g
- ISBN-13: 9780128121009
- ISBN-10: 0128121009
- Artikelnr.: 51569963
- Verlag: Elsevier Science Publishing Co Inc
- 2 ed
- Seitenzahl: 848
- Erscheinungstermin: 17. April 2018
- Englisch
- Abmessung: 276mm x 216mm x 46mm
- Gewicht: 276g
- ISBN-13: 9780128121009
- ISBN-10: 0128121009
- Artikelnr.: 51569963
SECTION I. PHARMACOLOGICAL AND CLINICAL APPLICATIONS1. Overview of Brain
Tumor Epidemiology and Histopathology2. Clinical Pharmacology of Brain
Tumor Chemotherapy3. Antiepileptic drugs and chemotherapy: Potential
interactions and impact on treatment of patients with cancer4. Brain Tumor
Models for Cancer Therapy5. Genomics and proteomics in neuro-oncology6.
Chemotherapy Resistance7. Clinical Trial Design and Implementation in
Neuro-Oncology8. Biology of the Blood-Brain and Blood-Brain Tumor Barriers
SECTION II. INNOVATIVE CHEMOTHERAPY DELIVERY9. Intra-arterial
Chemotherapy10. Blood-Brain Barrier Disruption Chemotherapy11. Interstitial
Chemotherapy and Polymer-Drug Delivery12. Intratumoral Chemotherapy and
Convection-Enhanced Delivery13. Marrow-Ablative Chemotherapy with
Autologous Hematopoietic Progenitor Cell Rescue in Brain Tumors14. CSF
Dissemination of Primary Brain Tumors 15. Gene/Viral Treatment Approaches
for Malignant Brain Cancer16. Nanoparticles as Therapeutic Agents for Brain
Tumors
SECTION III. MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS17. Overview of
Molecular Genetics of Brain Tumors18. Cell Cycle Regulation19. Targeting
cell cycle proteins in brain cancer20. Apoptosis Pathways and Chemotherapy
in Brain Tumors21. Growth Factor Signaling Pathways and Targeted Therapy22.
Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas23. PI3-kinase,
Akt, mTOR and Treatment24. Scatter Factor/HGF and C-MET in Glioblastoma25.
Targeting the sonic hedgehog pathway in brain cancers: Advances,
limitations, and future directions26. Angiogenesis and angiogenesis
inhibitors in brain tumors27. Bevacizumab and Brain Tumors28. Histone
Deacetylase Inhibitors as Therapeutic Agents
SECTION IV. CHEMOTHERAPY FOR SPECIFIC TUMORS - ADULTS 29. Historial and
conventional chemotherapy approaches for high grade astrocytomas 30. The
use of temozolomide for chemo-radiation and adjuvant therapy of high-grade
gliomas31. Molecular Treatment of High-Grade Glioma32. Chemotherapy of
Low-Grade Astrocytomas33. Chemotherapy of Oligodendrogliomas34.
Chemotherapy of Primary Central Nervous System Lymphoma35. Chemotherapy for
Medulloblastoma in Adults36. Chemotherapy of Adult Ependymoma 37.
Chemotherapy for Glioneuronal Tumors38. Medical therapy of Schwannomas 39.
Chemotherapy of Pineal Parenchymal Tumors40. Chemotherapy of Meningiomas41.
Chemotherapy of Brain Metastases
SECTION V. CHEMOTHERAPY FOR SPECIFIC TUMORS - PEDIATRICS42. Chemotherapy of
Pediatric Low-Grade Gliomas43. Chemotherapy of Pediatric High-Grade
Gliomas44. Chemotherapy for Medulloblastoma45. Chemotherapy of Brainstem
Gliomas46. Germ Cell Tumors47. Chemotherapy of Ependymoma - Childhood48.
Chemotherapy for CNS Atypical Teratoid/Rhabdoid Tumor49. Chemotherapy of
Central Nervous System Primitive Neuro-Ectodermal Tumors50. Pediatric
Choroid Plexus Carcinoma: Current Management and Future Directions
SECTION VI. IMMUNOTHERAPY OF BRAIN TUMORS51. The Immune Response to
Glioblastoma: Overview and Focus on Checkpoint Blockade52. Blockade of the
Checkpoint Inhibitor Pathways and Activated T-cell Therapy in Brain
Tumors53. Overview of Dendritic Cell Vaccines for Brain Tumors54. Overview
of Vaccine Strategies against Epidermal Growth Factor Receptor in Brain
Tumors55. Overview of CNS Vaccines - Pediatrics
SECTION VII. RESPONSE ASSESSMENT, QUALITY OF LIFE, AND NEUROPSYCHOLOGY56.
Issues in Response Assessment of Brain Tumor Chemotherapy57.
Pseudoprogression in Neuro-Oncology: Overview, Pathophysiology, and
Interpretation58. Response assessment in neuro-oncology (RANO): An update
59. Immunotherapy Response Assessment in Neuro-Oncology (iRANO)60. Quality
of Life in Neuro-Oncology61. Neuropsychology of Chemotherapy in Brain Tumor
Patients
Tumor Epidemiology and Histopathology2. Clinical Pharmacology of Brain
Tumor Chemotherapy3. Antiepileptic drugs and chemotherapy: Potential
interactions and impact on treatment of patients with cancer4. Brain Tumor
Models for Cancer Therapy5. Genomics and proteomics in neuro-oncology6.
Chemotherapy Resistance7. Clinical Trial Design and Implementation in
Neuro-Oncology8. Biology of the Blood-Brain and Blood-Brain Tumor Barriers
SECTION II. INNOVATIVE CHEMOTHERAPY DELIVERY9. Intra-arterial
Chemotherapy10. Blood-Brain Barrier Disruption Chemotherapy11. Interstitial
Chemotherapy and Polymer-Drug Delivery12. Intratumoral Chemotherapy and
Convection-Enhanced Delivery13. Marrow-Ablative Chemotherapy with
Autologous Hematopoietic Progenitor Cell Rescue in Brain Tumors14. CSF
Dissemination of Primary Brain Tumors 15. Gene/Viral Treatment Approaches
for Malignant Brain Cancer16. Nanoparticles as Therapeutic Agents for Brain
Tumors
SECTION III. MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS17. Overview of
Molecular Genetics of Brain Tumors18. Cell Cycle Regulation19. Targeting
cell cycle proteins in brain cancer20. Apoptosis Pathways and Chemotherapy
in Brain Tumors21. Growth Factor Signaling Pathways and Targeted Therapy22.
Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas23. PI3-kinase,
Akt, mTOR and Treatment24. Scatter Factor/HGF and C-MET in Glioblastoma25.
Targeting the sonic hedgehog pathway in brain cancers: Advances,
limitations, and future directions26. Angiogenesis and angiogenesis
inhibitors in brain tumors27. Bevacizumab and Brain Tumors28. Histone
Deacetylase Inhibitors as Therapeutic Agents
SECTION IV. CHEMOTHERAPY FOR SPECIFIC TUMORS - ADULTS 29. Historial and
conventional chemotherapy approaches for high grade astrocytomas 30. The
use of temozolomide for chemo-radiation and adjuvant therapy of high-grade
gliomas31. Molecular Treatment of High-Grade Glioma32. Chemotherapy of
Low-Grade Astrocytomas33. Chemotherapy of Oligodendrogliomas34.
Chemotherapy of Primary Central Nervous System Lymphoma35. Chemotherapy for
Medulloblastoma in Adults36. Chemotherapy of Adult Ependymoma 37.
Chemotherapy for Glioneuronal Tumors38. Medical therapy of Schwannomas 39.
Chemotherapy of Pineal Parenchymal Tumors40. Chemotherapy of Meningiomas41.
Chemotherapy of Brain Metastases
SECTION V. CHEMOTHERAPY FOR SPECIFIC TUMORS - PEDIATRICS42. Chemotherapy of
Pediatric Low-Grade Gliomas43. Chemotherapy of Pediatric High-Grade
Gliomas44. Chemotherapy for Medulloblastoma45. Chemotherapy of Brainstem
Gliomas46. Germ Cell Tumors47. Chemotherapy of Ependymoma - Childhood48.
Chemotherapy for CNS Atypical Teratoid/Rhabdoid Tumor49. Chemotherapy of
Central Nervous System Primitive Neuro-Ectodermal Tumors50. Pediatric
Choroid Plexus Carcinoma: Current Management and Future Directions
SECTION VI. IMMUNOTHERAPY OF BRAIN TUMORS51. The Immune Response to
Glioblastoma: Overview and Focus on Checkpoint Blockade52. Blockade of the
Checkpoint Inhibitor Pathways and Activated T-cell Therapy in Brain
Tumors53. Overview of Dendritic Cell Vaccines for Brain Tumors54. Overview
of Vaccine Strategies against Epidermal Growth Factor Receptor in Brain
Tumors55. Overview of CNS Vaccines - Pediatrics
SECTION VII. RESPONSE ASSESSMENT, QUALITY OF LIFE, AND NEUROPSYCHOLOGY56.
Issues in Response Assessment of Brain Tumor Chemotherapy57.
Pseudoprogression in Neuro-Oncology: Overview, Pathophysiology, and
Interpretation58. Response assessment in neuro-oncology (RANO): An update
59. Immunotherapy Response Assessment in Neuro-Oncology (iRANO)60. Quality
of Life in Neuro-Oncology61. Neuropsychology of Chemotherapy in Brain Tumor
Patients
SECTION I. PHARMACOLOGICAL AND CLINICAL APPLICATIONS1. Overview of Brain
Tumor Epidemiology and Histopathology2. Clinical Pharmacology of Brain
Tumor Chemotherapy3. Antiepileptic drugs and chemotherapy: Potential
interactions and impact on treatment of patients with cancer4. Brain Tumor
Models for Cancer Therapy5. Genomics and proteomics in neuro-oncology6.
Chemotherapy Resistance7. Clinical Trial Design and Implementation in
Neuro-Oncology8. Biology of the Blood-Brain and Blood-Brain Tumor Barriers
SECTION II. INNOVATIVE CHEMOTHERAPY DELIVERY9. Intra-arterial
Chemotherapy10. Blood-Brain Barrier Disruption Chemotherapy11. Interstitial
Chemotherapy and Polymer-Drug Delivery12. Intratumoral Chemotherapy and
Convection-Enhanced Delivery13. Marrow-Ablative Chemotherapy with
Autologous Hematopoietic Progenitor Cell Rescue in Brain Tumors14. CSF
Dissemination of Primary Brain Tumors 15. Gene/Viral Treatment Approaches
for Malignant Brain Cancer16. Nanoparticles as Therapeutic Agents for Brain
Tumors
SECTION III. MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS17. Overview of
Molecular Genetics of Brain Tumors18. Cell Cycle Regulation19. Targeting
cell cycle proteins in brain cancer20. Apoptosis Pathways and Chemotherapy
in Brain Tumors21. Growth Factor Signaling Pathways and Targeted Therapy22.
Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas23. PI3-kinase,
Akt, mTOR and Treatment24. Scatter Factor/HGF and C-MET in Glioblastoma25.
Targeting the sonic hedgehog pathway in brain cancers: Advances,
limitations, and future directions26. Angiogenesis and angiogenesis
inhibitors in brain tumors27. Bevacizumab and Brain Tumors28. Histone
Deacetylase Inhibitors as Therapeutic Agents
SECTION IV. CHEMOTHERAPY FOR SPECIFIC TUMORS - ADULTS 29. Historial and
conventional chemotherapy approaches for high grade astrocytomas 30. The
use of temozolomide for chemo-radiation and adjuvant therapy of high-grade
gliomas31. Molecular Treatment of High-Grade Glioma32. Chemotherapy of
Low-Grade Astrocytomas33. Chemotherapy of Oligodendrogliomas34.
Chemotherapy of Primary Central Nervous System Lymphoma35. Chemotherapy for
Medulloblastoma in Adults36. Chemotherapy of Adult Ependymoma 37.
Chemotherapy for Glioneuronal Tumors38. Medical therapy of Schwannomas 39.
Chemotherapy of Pineal Parenchymal Tumors40. Chemotherapy of Meningiomas41.
Chemotherapy of Brain Metastases
SECTION V. CHEMOTHERAPY FOR SPECIFIC TUMORS - PEDIATRICS42. Chemotherapy of
Pediatric Low-Grade Gliomas43. Chemotherapy of Pediatric High-Grade
Gliomas44. Chemotherapy for Medulloblastoma45. Chemotherapy of Brainstem
Gliomas46. Germ Cell Tumors47. Chemotherapy of Ependymoma - Childhood48.
Chemotherapy for CNS Atypical Teratoid/Rhabdoid Tumor49. Chemotherapy of
Central Nervous System Primitive Neuro-Ectodermal Tumors50. Pediatric
Choroid Plexus Carcinoma: Current Management and Future Directions
SECTION VI. IMMUNOTHERAPY OF BRAIN TUMORS51. The Immune Response to
Glioblastoma: Overview and Focus on Checkpoint Blockade52. Blockade of the
Checkpoint Inhibitor Pathways and Activated T-cell Therapy in Brain
Tumors53. Overview of Dendritic Cell Vaccines for Brain Tumors54. Overview
of Vaccine Strategies against Epidermal Growth Factor Receptor in Brain
Tumors55. Overview of CNS Vaccines - Pediatrics
SECTION VII. RESPONSE ASSESSMENT, QUALITY OF LIFE, AND NEUROPSYCHOLOGY56.
Issues in Response Assessment of Brain Tumor Chemotherapy57.
Pseudoprogression in Neuro-Oncology: Overview, Pathophysiology, and
Interpretation58. Response assessment in neuro-oncology (RANO): An update
59. Immunotherapy Response Assessment in Neuro-Oncology (iRANO)60. Quality
of Life in Neuro-Oncology61. Neuropsychology of Chemotherapy in Brain Tumor
Patients
Tumor Epidemiology and Histopathology2. Clinical Pharmacology of Brain
Tumor Chemotherapy3. Antiepileptic drugs and chemotherapy: Potential
interactions and impact on treatment of patients with cancer4. Brain Tumor
Models for Cancer Therapy5. Genomics and proteomics in neuro-oncology6.
Chemotherapy Resistance7. Clinical Trial Design and Implementation in
Neuro-Oncology8. Biology of the Blood-Brain and Blood-Brain Tumor Barriers
SECTION II. INNOVATIVE CHEMOTHERAPY DELIVERY9. Intra-arterial
Chemotherapy10. Blood-Brain Barrier Disruption Chemotherapy11. Interstitial
Chemotherapy and Polymer-Drug Delivery12. Intratumoral Chemotherapy and
Convection-Enhanced Delivery13. Marrow-Ablative Chemotherapy with
Autologous Hematopoietic Progenitor Cell Rescue in Brain Tumors14. CSF
Dissemination of Primary Brain Tumors 15. Gene/Viral Treatment Approaches
for Malignant Brain Cancer16. Nanoparticles as Therapeutic Agents for Brain
Tumors
SECTION III. MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS17. Overview of
Molecular Genetics of Brain Tumors18. Cell Cycle Regulation19. Targeting
cell cycle proteins in brain cancer20. Apoptosis Pathways and Chemotherapy
in Brain Tumors21. Growth Factor Signaling Pathways and Targeted Therapy22.
Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas23. PI3-kinase,
Akt, mTOR and Treatment24. Scatter Factor/HGF and C-MET in Glioblastoma25.
Targeting the sonic hedgehog pathway in brain cancers: Advances,
limitations, and future directions26. Angiogenesis and angiogenesis
inhibitors in brain tumors27. Bevacizumab and Brain Tumors28. Histone
Deacetylase Inhibitors as Therapeutic Agents
SECTION IV. CHEMOTHERAPY FOR SPECIFIC TUMORS - ADULTS 29. Historial and
conventional chemotherapy approaches for high grade astrocytomas 30. The
use of temozolomide for chemo-radiation and adjuvant therapy of high-grade
gliomas31. Molecular Treatment of High-Grade Glioma32. Chemotherapy of
Low-Grade Astrocytomas33. Chemotherapy of Oligodendrogliomas34.
Chemotherapy of Primary Central Nervous System Lymphoma35. Chemotherapy for
Medulloblastoma in Adults36. Chemotherapy of Adult Ependymoma 37.
Chemotherapy for Glioneuronal Tumors38. Medical therapy of Schwannomas 39.
Chemotherapy of Pineal Parenchymal Tumors40. Chemotherapy of Meningiomas41.
Chemotherapy of Brain Metastases
SECTION V. CHEMOTHERAPY FOR SPECIFIC TUMORS - PEDIATRICS42. Chemotherapy of
Pediatric Low-Grade Gliomas43. Chemotherapy of Pediatric High-Grade
Gliomas44. Chemotherapy for Medulloblastoma45. Chemotherapy of Brainstem
Gliomas46. Germ Cell Tumors47. Chemotherapy of Ependymoma - Childhood48.
Chemotherapy for CNS Atypical Teratoid/Rhabdoid Tumor49. Chemotherapy of
Central Nervous System Primitive Neuro-Ectodermal Tumors50. Pediatric
Choroid Plexus Carcinoma: Current Management and Future Directions
SECTION VI. IMMUNOTHERAPY OF BRAIN TUMORS51. The Immune Response to
Glioblastoma: Overview and Focus on Checkpoint Blockade52. Blockade of the
Checkpoint Inhibitor Pathways and Activated T-cell Therapy in Brain
Tumors53. Overview of Dendritic Cell Vaccines for Brain Tumors54. Overview
of Vaccine Strategies against Epidermal Growth Factor Receptor in Brain
Tumors55. Overview of CNS Vaccines - Pediatrics
SECTION VII. RESPONSE ASSESSMENT, QUALITY OF LIFE, AND NEUROPSYCHOLOGY56.
Issues in Response Assessment of Brain Tumor Chemotherapy57.
Pseudoprogression in Neuro-Oncology: Overview, Pathophysiology, and
Interpretation58. Response assessment in neuro-oncology (RANO): An update
59. Immunotherapy Response Assessment in Neuro-Oncology (iRANO)60. Quality
of Life in Neuro-Oncology61. Neuropsychology of Chemotherapy in Brain Tumor
Patients